Log In
Print
BCIQ
Print
Print this Print this
 

FR104

Also known as: Anti-CD28 antibody fragments

  Manage Alerts
Collapse Summary General Information
Company Effimune S.A.S
DescriptionHuman mAb CD28 antagonist
Molecular Target CD28 receptor
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationOrgan transplant rejection
Indication DetailsPrevent kidney transplant rejection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today